tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GMAB Stock Latest News

Genmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
Company AnnouncementsGenmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
11d ago
6K
GMAB
GMAB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
GMAB Upcoming Earnings Report: What to Expect?
11d ago
GMAB
Genmab Grants New RSUs and Warrants to Employees to Strengthen Long-Term Incentives
PremiumCompany Announcements
Genmab Grants New RSUs and Warrants to Employees to Strengthen Long-Term Incentives
16d ago
6K
GMAB
AI Daily: Nvidia invests $2B in CoreWeave
PremiumThe Fly
AI Daily: Nvidia invests $2B in CoreWeave
19d ago
LLY
NVS
Drugmakers use AI to help progress through trials, submissions, Reuters says
PremiumThe Fly
Drugmakers use AI to help progress through trials, submissions, Reuters says
19d ago
GSK
LLY
Genmab Reports 2025 DARZALEX Net Sales of USD 14.4 Billion
PremiumCompany AnnouncementsGenmab Reports 2025 DARZALEX Net Sales of USD 14.4 Billion
24d ago
6K
GMAB
Genmab reports worldwide net sales of Darzalex in 2025 totaled $14.351B
Premium
The Fly
Genmab reports worldwide net sales of Darzalex in 2025 totaled $14.351B
24d ago
JNJ
GMAB
Genmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
Premium
Ratings
Genmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
25d ago
GMAB
Genmab price target lowered to $39 from $41 at H.C. Wainwright
PremiumThe Fly
Genmab price target lowered to $39 from $41 at H.C. Wainwright
25d ago
GMAB
Genmab price target raised to $38.50 from $34.70 at BofA
PremiumThe Fly
Genmab price target raised to $38.50 from $34.70 at BofA
26d ago
GMAB
Maintaining Buy on Genmab: Epkinly Combination Potential Outweighs Monotherapy Setback
PremiumRatings
Maintaining Buy on Genmab: Epkinly Combination Potential Outweighs Monotherapy Setback
26d ago
GMAB
Genmab: Limited Epkinly Approval Risk and High-Value 2026 Pipeline Catalysts Support Buy Rating
PremiumRatings
Genmab: Limited Epkinly Approval Risk and High-Value 2026 Pipeline Catalysts Support Buy Rating
29d ago
GMAB
Truist maintains optimism for 2026 read-out after Genmab’s Phase 3 trial OS miss
PremiumThe FlyTruist maintains optimism for 2026 read-out after Genmab’s Phase 3 trial OS miss
29d ago
GMAB
Genmab Reports Positive Phase 3 Progression-Free Survival Data for Epcoritamab in Relapsed/Refractory DLBCL
Premium
Company Announcements
Genmab Reports Positive Phase 3 Progression-Free Survival Data for Epcoritamab in Relapsed/Refractory DLBCL
29d ago
6K
GMAB
AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial
Premium
The Fly
AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial
29d ago
ABBV
GMAB
Genmab AS trading resumes
PremiumThe Fly
Genmab AS trading resumes
29d ago
GMAB
Genmab says OS in Phase 3 trial did not reach statistical significance
PremiumThe Fly
Genmab says OS in Phase 3 trial did not reach statistical significance
29d ago
ABBV
GMAB
Genmab AS trading halted, news pending
PremiumThe Fly
Genmab AS trading halted, news pending
29d ago
GMAB
Genmab price target raised to DKK 2,400 from DKK 2,000 at Deutsche Bank
PremiumThe Fly
Genmab price target raised to DKK 2,400 from DKK 2,000 at Deutsche Bank
1M ago
GMAB
Genmab partners with Anthropic to accelerate R&D through agentic AI
PremiumThe FlyGenmab partners with Anthropic to accelerate R&D through agentic AI
1M ago
GMAB
Genmab price target raised to DKK 2,400 from DKK 2,000 at Deutsche Bank
Premium
The Fly
Genmab price target raised to DKK 2,400 from DKK 2,000 at Deutsche Bank
1M ago
GMAB
Genmab price target raised to DKK 2,500 from DKK 2,000 at Barclays
Premium
The Fly
Genmab price target raised to DKK 2,500 from DKK 2,000 at Barclays
1M ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >